FBRX
Forte Biosciences Inc
77.00$
+0.0%
vs. previous close
Closing price · As of: Aug 28, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 150.0% | – | – | 26.3% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 100.0% | – | – | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | -150.0% | – | – | -26.3% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 9,588.9% | 3,444.4% | 3,922.2% | 84,400.0% | 15,044.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 59,450.0% | 72,550.0% | – | – | 13,763.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 3,600.0% | 3,544.4% | 3,677.8% | 34,611.1% | 7,477.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 46,900.0% | 57,516.7% | – | – | 5,581.6% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 13,166.7% | 6,988.9% | 7,600.0% | 103,022.2% | 22,522.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 106,250.0% | 129,916.7% | – | – | 19,318.4% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -13,188.9% | -6,988.9% | -7,600.0% | -102,922.2% | -22,522.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -106,350.0% | -130,066.7% | – | – | -19,344.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 2,366.7% | 8,488.9% | 21,922.2% | 1,477.8% | 8,400.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,700.0% | 1,700.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -13,166.7% | -7,000.0% | -7,666.7% | -117,588.9% | -22,777.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -97,866.7% | -123,666.7% | – | – | -18,828.9% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -4,733.3% | -2,411.1% | -7,600.0% | 11.1% | 11.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,900.6% | -571.3% | – | – | 90.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -13,166.7% | -7,000.0% | -7,666.7% | -117,588.9% | -22,777.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -97,866.7% | -123,666.7% | – | – | -18,828.9% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -189,788.9% | -6,988.9% | -7,600.0% | -111,855.6% | -22,377.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -106,250.0% | -123,516.7% | – | – | -18,802.6% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.